A team of scientists from the Drug Discovery Unit, University of Dundee have identified a novel antimalarial compound. As per their press release, the details of the discovery, properties and mechanism of action of a novel antimalarial compound, DDD107498, have been published in the journal Nature. DDD107498 has the potential to treat malaria patients in a single dose, including those with malarial parasites resistant to current medications, and also helps reduce the transmission of the parasite.
WHO reported 200 million clinical cases of malaria in 2013, with 584,000 people dying from the disease. Most of these deaths were children under the age of 5 and pregnant women. The University of Dundee team has been working with Medicines for Malaria Venture (MMV) since 2009 to identify potential new treatments for malaria. The project was initiated by testing a collection of around 4,700 compounds at the University of Dundee…
View original post 717 more words